IDEXX > Livestock/Poultry Testing > Newsletter > November 2003 Edition
 

IDEXX Animal Health Updates

your timely update of animal health and diagnostics information.

November 2003 Worldwide Edition

 

IN THIS ISSUE

THE LATEST NEWS

Ruminant Silhouette In Ruminant Testing
Brucella abortus and Brucella melitensis—organisms that can cause reproductive disease in ruminants and potentially in humans
 

Disease
Brucella, particularly Brucella abortus (B. abortus), is the causative agent of bovine brucellosis. In some countries with close association between cattle, sheep and goats, infection can also be caused by Brucella melitensis (B. melitensis). B. melitensis is the principal organism that causes reproductive disease in small ruminants.

In 1887, Sir David Bruce described B. melitensis causing abortion in sheep and goats as the cause of Malta fever in humans. In 1897, the Danish veterinarian Frederik Bang found a relation between B. abortus and abortion in cattle.16 B. abortus and B. melitensis are also causes of undulant fever in humans.8 Abortion in cows, mostly in the first three months of pregnancy or after seven months due to placentitis without any other signs of disease, is the most outstanding clinical feature of the disease. If a carrier state develops, in the majority of the infected cows, the clinical manifestations may be reduced milk production, infertility and resorption of the fetus, and a higher frequency of retained placentas. Disease in bulls may produce infection of the seminal vesicles and testicles, causing orchitis and epidymitis, which can result in shedding of the organism in semen. Long-standing infections may result in arthritis, tendonitis and bursitis in some cattle (Figure 1).

 
Figure 1
Brucella infected cow
Arthritis and bursitis due to chronic Brucella infection.
Photo courtesy of H. Seifert, Göttingen.
 

In sheep and goats, B. melitensis is the principal cause of abortion, with occasional abortion due to B. abortus.

 

Table 1: Brucella species, their hosts and clinical signs of disease.

Species Host Disease
B. abortus cattle, sheep, goat, swine, horses, humans abortion, orchitis, bursitis, undulant fever
B. melitensis goat, sheep, cattle, humans abortion, sporadic abortion, Malta fever
B. suis swine, humans abortion, orchitis, arthritis, spondylitis, undulant fever
B. ovis sheep epididymitis, sporadic abortion
B. canis dog, human abortion, epididymitis, discospondylitis, infertility, undulant fever
B. neotomae Neotomae lepida (round worm) apathogen
 

The primary modes of disease transmission are direct by copulation, or indirect by ingestion of infected tissue of aborted fetuses, fetal membranes, uterine fluids or milk. Transmission by artificial insemination may occur as well.

 

Brucella spp.
Brucella spp. are facultative intracellular, small Gram-negative coccoid rods. They are rigid and do not have a capsule. Brucellae are able to grow in either aerobic or microaerophilic conditions, and have special requirements for culture. There are smooth and rough forms of culture colonies based on lipopolysaccharide expression (Figure 2). For B. abortus and B. melitensis, the smooth strains are considered virulent.7

 
Figure 2
Brucella colonies
Brucella colonies (R-strains and S-strains) under reflected light.
Photo courtesy of J. Stack, VLA Weybridge.
 

Pasteurization and disinfectants easily inactivate Brucella spp. However, the organisms can survive in urine for several days, in manure for several months, in milk for six weeks, in butter for four months and in meat stored in packing plant coolers for 14 days.14

 

Zoonotic risk
B. abortus and B. melitensis are zoonotic agents. Infection may occur via either the conjunctiva or abraded skin, but ingestion of contaminated dairy products constitutes the main risk to the public.3 In 2000, the EU member states reported 2857 cases of brucellosis in humans compared to 3899 in 1999.9 Brucella spp. may cause orchitis, chronic arthritis and infertility in humans.

Veterinarians and farmers who work with Brucella-infected ruminants and consumers of raw milk products from infected animals are at risk for abortion, orchitis, chronic arthritis and infertility.12

 

Scope
Several member states of the EU have already gained an official status of being free of bovine brucellosis (Austria, Denmark, Finland, Germany, Luxembourg, Sweden and the province of Bolzano in Italy). The Netherlands, Great Britain and Norway are officially bovine brucellosis-free as well. In most of the other member states of the EU, eradication programs for bovine brucellosis have been implemented.9

While nine members of the EU are recognized as officially free of B. melitensis, four EU member states have not yet reached this status for any of their regions. In Greece, ovine and caprine brucellosis due to B. melitensis is a significant problem for human health and animal production.9

The United States is free of brucellosis except for Texas and Missouri, which are almost free. Australia has been free of bovine brucellosis since 1992.4 In Central and South America and eastern European countries, brucellosis is still a serious problem.

In dairy farms with intensive production in tropical areas, up to 80% of the cattle can be infected. For extensive beef and milk farms in the Sahel region in Africa, up to 30% of the cattle are assumed to be infected.14

 

Diagnosis
For direct diagnosis of Brucella spp., microscopic evaluation of stained smears from aborted tissue or cultured material, immunofluorescence staining, phage typing and PCR are commonly used.

The diagnosis of bovine brucellosis is almost exclusively based on serological tests for the detection of antibodies to B. abortus and B. melitensis.10

A variety of serological tests can be used:

  • Serum agglutination test (SAT)
  • Plate agglutination
  • Card test (rose-bengal-test)
  • Mercaptoethanol test
  • Rivanol agglutination test
  • Agar gel immunodiffusion
  • Complement fixation
  • Brucella ring test (Bang ring test)
  • ELISA

The OIE and the EU have implemented recommendations and guidelines for the use of these serological tests. Because the serum agglutination test is unsatisfactory for the detection of bovine brucellosis, it is no longer recommended by the OIE.3 Because the diagnostic performance of some enzyme-linked immunosorbent assays and the fluorescence polarization assay are comparable with, or better than, that of complement fixations tests, and because they are more robust and simpler to perform, their use may be preferred.11, 15 All serological brucellosis tests show to a different extent cross-reactivity with LPS antigens from other bacteria, such as Yersinia enterocolitica (0:3, 0:6, 0:9) or E. coli (O157:H7).

Serological techniques are the mainstay of diagnosis and mass testing programs. The most successful of the serological diagnostic tests for B. abortus and B. melitensis are based on the detection of antibodies to LPS antigen of smooth Brucella strains.10

 

IDEXX HerdChek* Brucella Antibody Tests
IDEXX Laboratories offers three ELISA systems for the detection of antibody to Brucella:

HerdChek Brucella abortus Antibody Test Kit
The HerdChek B. abortus test is an indirect enzyme immunoassay for the detection of antibody to Brucella abortus in bovine milk samples, using LPS antigens.

  • Six-strip microtiter plate format
  • Detects antibodies to Brucella LPS antigens
  • Brucella abortus strain 1199/3 antigen
  • Monoclonal IgG1 conjugate
  • Sensitive to test bulk milk of up to 200 milk samples
  • Easy-to-use reagents
  • Kit interpretation guidelines for areas using vaccination to control B. abortus, and for B. abortus-free or nonvaccinated populations

For more information, download the information sheet. (66 KB)

Note: Only the indirect ELISA format is recommended by the OIE to test milk samples.3

HerdChek Brucella abortus Antibody Test Kit (Serum)
Available only through IDEXX Europe

The HerdChek B. abortus (Serum) test is an indirect enzyme immunoassay for the detection of antibody to Brucella abortus in bovine serum samples, using LPS antigens.

  • Six-strip microtiter plate format
  • Detects antibodies to Brucella LPS antigens
  • Brucella abortus strain 1199/3 antigen
  • Monoclonal IgG1 conjugate
  • Ready-to-use reagents

IDEXX has validated this test for testing pools of 10 serum or plasma samples (data on file). Contact IDEXX Technical Services for more information. In the U.S., call 1-800-943-3999. Outside the U.S., contact your local IDEXX representative.

For more information, download the information sheet. (66 KB)

HerdChek Brucellosis Antibody Test Kit (small ruminant, sheep and goats)
Available only through IDEXX Europe

  • Optimized for the detection of antibody to Brucella spp. in serum samples from sheep and goat
  • For use in conjunction with the HerdChek B. abortus Antibody Test Kit (Serum)

 

Disease control and eradication
There are two approaches: vaccination for disease control and "test and cull" for disease eradication.

Vaccination of calves with B. abortus strain 19 increases resistance to infection, but protection may not be complete and some vaccinated cattle may become infected. Also some vaccinated cattle may develop antibodies that interfere with diagnostic test results. Strain RB 51 vaccine from an attenuated rough B. abortus strain has largely replaced strain 19 vaccines because it does not cause production of antibodies that interfere with serological tests.1 But the RB 51 vaccine can cause infection in calves if administered to pregnant cattle. Even humans can be at risk for infection with RB 51 if they have contact with aborted infected tissue, placenta, blood or amniotic fluid without wearing gloves, masks or eye protection. Another potential risk for health hazard is vaccine administration by unintentional needle stick injuries.5 For brucellosis vaccines, there have been cases of suspected or confirmed adverse effects in humans reported.2

Vaccination can help to reduce the number of reactors, but when proceeding from a control to an eradication program, a test and slaughter program is necessary.1 Countries that are free of brucellosis or that have implemented brucellosis-control programs may require Brucella spp.-free certification prior to shipping cattle into their regions.

In areas with high prevalence of brucellosis, testing individual serum, plasma or milk samples is a highly sensitive diagnostic tool that is recommended by the OIE Manual of Standards for Diagnostic Tests and Vaccines and by the EU regulation number 535/2002, Directive 64/432.6 In regions with low prevalence of brucellosis, testing serum or plasma pools of 10 samples or bulk milk samples is a very cost-efficient and reliable diagnostic tool for surveillance testing.

 
OIE recommended
Fulfills the requirements of Annex C to Directive 64/432/EEC, data on file
 

References:

1.

Aiello SE, Mays A, eds. Brucellosis in cattle. In: The Merck Veterinary Manual. Whitehouse Station, N.J.: Merck; 1998:999–1000.

2.

Berkelman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis. 2003;37(3):407–414.

3.

OIE. Bovine brucellosis. In: OIE Manual of Standards for Diagnostic Tests and Vaccines. Paris, France:OIE; 2000:328–345.

4.

Bunn C. Eradication of bovine brucellosis in Australia. Available at:http://www.vetsci.usyd.edu.au/avhs/milestones. Accessed October 17, 2003.

5.

CDC. Human Exposure to Brucella abortus Strain RB 51. Available at: http://wonder.cdc.gov/wonder/prevguid/m0051495/m0051495.asp. Accessed October, 17, 2003.

6.

Commission Regulation (EC) No 535/2002, amending Annex C to Council Directive 64/432/EEC and amending Decision 2000/330/EC.

7.

Dalrympe-Champneys W. Brucella Infection and Undulant fever in Man. London: Oxford University Press; 1960.

8.

Godfroid J, Käsbohrer A. Brucellosis in the European Union and Norway at the turn of the twenty-first century. Vet Microbiology. 2002;90:135–145.

9.

Godfroid J, Saegerman C, Wellemans V, et al. How to substantiate eradication of bovine brucellosis when aspecific serological reactions occur in the course of brucellosis testing. Vet Microbiology. 2002;90:461–477.

10.

McGiven JA, Tucker JD, Perrett LL, Stack JA, Brew SD, MacMillan AP. Validation of FPA and cELISA for the detection of antibodies to Brucella abortus in cattle sera and comparison to SAT, CFT and iELISA. J Imm Meth. 2003;278:171–178.

11.

Nielsen K, Kelly L, Gall D, et al. Comparison of enzyme immunoassays for the diagnosis of bovine brucellosis. Prev.Vet. Med. 1996;26:17–32.

12.

Paptsoris AG, Mpadra FA, Karamouzis MV, Frangides CY. Endemic brucellar epididymo-orchitis: a 10-year experience. In: Int J Infect Dis. 2002;6(4):309–13.

13.

Seifert HSH. Brucellosen. In: Tropical Animal Health. Dordrecht, Germany: Kluwer Academic Publishers. 1996.

14.

Weidmann H. Survey of means now available for combatting brucellosis in cattle production in the tropics. Anim Res Dev. 1991:33.

15.

Wright PF, Nilssone E, Van Rooij EMA, Lelenta M, Jeggo MH. Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis. Rev Sci Tech Off Int Epiz. 1993;12:435–450.

16.

Wiesner E, Ribbeck R, eds. Wörterbuch der Veterinärmedizin. Gustav-Fischer Verlag Jena. 1991:172.

 

The LATEST NEWS

Back to the Top

 In transmissible spongiform encephalopathy (TSE) testing
Three second-generation postmortem TSE products are in the late stages of development at IDEXX

The IDEXX Production Animal Services team has developed products for the detection of bovine spongiform encephalopathy (BSE), scrapie and chronic wasting disease (CWD). The tests represent significant advancements in postmortem TSE testing. Sample preparation is greatly simplified due to a novel chemical ligand licensed from Microsens Biotechnologies that selectively captures PrPSc in the presence of PrPC. These advancements have resulted in a second-generation test with no proteinase K treatment, no centrifugation, room-temperature incubation, less hands-on time and results in under 4.5 hours. The CWD test has been submitted to the USDA for approval in the United States, and the BSE and scrapie tests have been accepted into the current round of TSE diagnostic validation in the European Union. Stay tuned for further updates and announcements as these exciting new tests become approved for use.

 
 

TECHNICAL TIP OF THE MONTH

Back to the Top

Determination of kit expiration dates. Why is the kit's expiration date sooner than its components?

Initially, lots of individual components making up the test kit are tested to confirm performance is maintained over the long term. Based on this testing, the component is given a certain expiration date. Then, to determine the expiration date of the kit, there is multi-lot testing of the kit as a whole. This testing may show good performance past, for example, a 12-month expiration date, but to ensure the highest quality product throughout the life of the test kit, we may not give it the full dating observed in the other components. Lastly, we are limited by our outline of production on a kit-by-kit basis with the USDA, which specifies the allowable expiration dates for each kit.

 
 

LEARN MORE

Back to the Top

To learn more about our products and services, innovative technologies, trusted service and support, and our global offices, visit our Web site.

 
 

VISIT US AT THE FOLLOWING EVENTS

Back to the Top

Bangkok, Thailand—November 9–13, 2003
The 11th International Symposium of the World Association of Veterinary Laboratory Diagnosticians (ISWALD)

IDEXX will present on the following topics:

  • Comparison of the Novel, Rapid Seprion Assay and a Standard Proteinase K Immunoblotting Assay for the Detection of BSE and other Transmissible Spongiform Encephalopathies

  • Current Data on Detection of BVDV and BDV Infection Using HerdChek* BVDV Antigen ELISA

  • Serological Monitoring of Salmonella Infection in Swine Using the HerdChek* Salmonella Antibody ELISA

Atlanta, Georgia, USA—January 28–30, 2004
The International Poultry Exposition (IPE)

 
 

PEOPLE ON THE MOVE

Back to the Top

Amie Carmillo joins the Production Animal Services team as a marketing associate in Westbrook, Maine, USA. She received a B.A and an M.S. in biology, and recently received an MBA from Babson College. Previously, she worked for Biogen, Inc.

 
 

NEWSLETTER ARCHIVE

To view past editions of IDEXX Animal Health Updates, visit our newsletter archive.

 
 

WE WANT TO HEAR FROM YOU

Back to the Top

...and we want you to hear from us! Pass the following link along to your friends and colleagues. They can register for Animal Health Updates to stay informed of the latest IDEXX products and services and respond to various customer and market surveys that we will soon offer. Registration is easy at www.idexx.com/production/livestockpoultrynews.

 

Questions or comments?

 
Unsubscribe to future communications.
 
* HerdChek is a trademark or a registered trademark of IDEXX Laboratories, Inc. in the United States and/or other countries. All other product and company names are trademarks or registered trademarks of their respective holders.
 

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.